Breaking News Instant updates and real-time market news.

2020-06-09 05:31:35 HSQVY Husqvarna $0.00 / + (+0.00%) 05:31 06/09/20 06/09 05:31 06/09/20 05:31	Husqvarna downgraded to Hold from Buy at Pareto Pareto analyst Frederik Moregard downgraded Husqvarna to Hold from Buy with an SEK 81 price target.

2020-06-09 05:31:35

HSQVY

Husqvarna

$0.00 / + (+0.00%)

05:31

06/09/20

06/09

05:31

06/09/20

05:31

Husqvarna downgraded to Hold from Buy at Pareto

Pareto analyst Frederik Moregard downgraded Husqvarna to Hold from Buy with an SEK 81 price target.

TODAY'S FREE FLY STORIES

Recommendations	Advanced Drainage price target raised to $98 from $89 at Barclays » 08:00 01/20/21 01/20 08:00 01/20/21 08:00 WMS Advanced Drainage $89.44 / +0.15 (+0.17%) Barclays analyst Matthew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events WMS Advanced Drainage $89.44 / +0.15 (+0.17%) 08/06/20 Advanced Drainage sees FY21 CapEx $60M-$65M WMS Advanced Drainage $89.44 / +0.15 (+0.17%) 12/18/20 Barclays Advanced Drainage price target raised to $89 from $77 at Barclays 12/16/20 Loop Capital Advanced Drainage price target raised to $88 from $75 at Loop Capital 10/12/20 Barclays Advanced Drainage price target raised to $77 from $64 at Barclays 10/07/20 Loop Capital Advanced Drainage price target raised to $75 from $67 at Loop Capital WMS Advanced Drainage $89.44 / +0.15 (+0.17%) 11/05/20 Advanced Drainage sees FY21 revenue $1.79B-$1.84B, consensus $1.82B 11/05/20 Advanced Drainage reports Q2 EPS 93c, consensus $1.05 08/06/20 Advanced Drainage reports Q1 EPS 83c, consensus 68c 11 Dec 02/04/21 Advanced Drainage - WMS
Downgrade	Redfin downgraded to Neutral from Buy at DA Davidson » 08:00 01/20/21 01/20 08:00 01/20/21 08:00 RDFN Redfin $76.64 / -0.08 (-0.10%) DA Davidson analyst Tom… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options RDFN Redfin $76.64 / -0.08 (-0.10%) 01/06/21 Redfin expands RedfinNow to Phoenix 10/13/20 Redfin reports U.S. luxury home sales increased 41.5% in Q3 09/11/20 Redfin says U.S. median home sale prices up 13% from last year 08/14/20 Tiger Global takes stake in ZoomInfo during Q2, exits iQIYI RDFN Redfin $76.64 / -0.08 (-0.10%) 01/19/21 Truist Truist keeps Buys on Redfin, Zillow into 'strong' 2021 housing start 01/12/21 BTIG Redfin downgraded to Neutral from Buy at BTIG, prefers Zillow Group 01/12/21 BTIG Redfin downgraded to Neutral from Buy at BTIG 01/06/21 Wedbush Redfin price target raised to $86 from $59 at Wedbush RDFN Redfin $76.64 / -0.08 (-0.10%) 11/06/20 Redfin reported Q3 EPS 30c, consensus 25c 11/05/20 Redfin sees Q4 revenue $226M-$233M, consensus $214.94M 11/05/20 Notable companies reporting after market close 10/15/20 Redfin sees Q3 revenue $235.0M, consensus $222.7M RDFN Redfin $76.64 / -0.08 (-0.10%) 08/13/20 Cost of mortgage refinancing 'about to go up,' NY Times reports RDFN Redfin $76.64 / -0.08 (-0.10%) 01/12/21 NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street 12/21/20 Microsoft, Walmart upgrades among today's top calls on Wall Street 11/05/20 Fly Intel: After-Hours Movers 09/25/20 Cruise Line upgrades among today's top calls on Wall Street RDFN Redfin $76.64 / -0.08 (-0.10%) 12/28/20 Redfin put volume heavy and directionally bearish 12/09/20 Redfin call volume above normal and directionally bullish 10/15/20 Redfin put volume heavy and directionally bearish 09/24/20 Redfin put volume heavy and directionally bearish
Options	Micron call buyer realizes 56% same-day gains » 08:00 01/20/21 01/20 08:00 01/20/21 08:00 MU Micron $85.49 / +4.76 (+5.90%) Notable profits for the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MU Micron $85.49 / +4.76 (+5.90%) 01/14/21 Micron director sells 50K shares of common stock 01/13/21 Micron's Arnzen sells 15,000 common shares 01/08/21 Micron CEO: We are in the sweet spot of market trends 01/07/21 Micron says data center revenue declined sequentially in Q1 MU Micron $85.49 / +4.76 (+5.90%) 01/19/21 Mizuho Micron not impacted by Xiaomi blacklist, says Mizuho 01/11/21 Citi December notebook shipments good news for Micron and Intel, says Citi 01/08/21 JPMorgan Micron price target raised to $100 from $85 at JPMorgan 01/08/21 Wells Fargo Wells Fargo says Micron remains 2021 Top Pick after Q1 report MU Micron $85.49 / +4.76 (+5.90%) 01/07/21 Micron sees Q2 EPS 75c +/- 7c, consensus 63c 01/07/21 Micron reports Q1 EPS 78c, consensus 71c 01/07/21 Notable companies reporting after market close 12/01/20 Micron raises Q1 adj. EPS view 69c-73c from 40c-54c, consensus 48c MU Micron $85.49 / +4.76 (+5.90%) 12/04/20 Micron fab power outage may impact global DRAM supply, DigiTimes reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says MU Micron $85.49 / +4.76 (+5.90%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/07/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: What to watch in Micron's earnings report 02/11/21 Technology & Internet Virtual Conference MU Micron $85.49 / +4.76 (+5.90%) 01/07/21 Micron options imply 9.7% move in share price post-earnings 01/05/21 Micron call volume above normal and directionally bullish 01/05/21 Early notable gainers among liquid option names on January 5th 01/05/21 Unusually active option classes on open January 5th
Earnings	BOK Financial reports Q4 EPS $2.21, consensus $1.92 » 07:59 01/20/21 01/20 07:59 01/20/21 07:59 BOKF BOK Financial $80.44 / +1.37 (+1.73%) The company's common… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events BOKF BOK Financial $80.44 / +1.37 (+1.73%) 01/04/21 Wells Fargo BOK Financial upgraded to Overweight from Equal Weight at Wells Fargo 10/26/20 Truist BOK Financial price target raised to $69 from $60 at Truist 10/22/20 RBC Capital BOK Financial price target raised to $66 from $60 at RBC Capital 03/09/20 Raymond James BOK Financial downgraded at Raymond James as oil prices sink BOKF BOK Financial $80.44 / +1.37 (+1.73%) 10/21/20 BOK Financial reports Q3 EPS $2.19, consensus $1.56 07/22/20 BOK Financial reports Q2 EPS 92c, consensus $1.12 02/02/21 Texas Bank Virtual Investor Trip 03/11/21 Virtual Atlanta and Texas Bank Summit 10:00 Today BOK Financial - BOKF
Initiation	Nidec initiated with a Buy at Jefferies » 07:59 01/20/21 01/20 07:59 01/20/21 07:59 NJDCY Nidec $0.00 / + (+0.00%) Jefferies analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News NJDCY Nidec $0.00 / + (+0.00%) 01/19/21 Nidec files patent infringement suit against Seagate

Recommendations	Arch Resources price target raised to $72 from $68 at B. Riley Securities » 07:58 01/20/21 01/20 07:58 01/20/21 07:58 ARCH Arch Resources $52.09 / +1.6 (+3.17%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ARCH Arch Resources $52.09 / +1.6 (+3.17%) 10/22/20 Arch Resources announces strategic plan for legacy thermal assets 09/02/20 Ramaco Resources appoints Barkley Sturgill as general counsel ARCH Arch Resources $52.09 / +1.6 (+3.17%) 01/15/21 B. Riley Securities Arch Resources price target raised to $68 from $66 at B. Riley Securities 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 06/30/20 B. Riley FBR Arch Resources price target lowered to $67 from $73 at B. Riley FBR 04/27/20 Jefferies Jefferies sees coal mining equities lagging, cuts ratings on three miners ARCH Arch Resources $52.09 / +1.6 (+3.17%) 10/22/20 Arch Resources reports Q3 EPS ($12.64), consensus ($1.04) 07/28/20 Arch Resources reports Q2 EPS ($3.26), consensus ($2.55)
Recommendations	Freeport McMoRan price target raised to $32 from $30 at B. Riley Securities » 07:58 01/20/21 01/20 07:58 01/20/21 07:58 FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 10/22/20 Freeport McMoRan: Makes more sense to develop mines than buy assets 10/22/20 Freeport McMoRan will be 'comfortable' when net debt falls to $5B 10/22/20 Freeport 'confident' in ability to recommend restored dividend in 2021 10/22/20 Freeport McMoRan: No decision yet on new smelter plan in Indonesia FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 01/13/21 Deutsche Bank Freeport McMoRan price target raised to $33 from $20 at Deutsche Bank 01/05/21 Fly Intel: Top five analyst upgrades 01/05/21 B. Riley Securities Freeport McMoRan price target raised to $30 from $26 at B. Riley Securities 01/05/21 Argus upgrades Freeport McMoRan to Buy on recovery in manufacturing and metals FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 10/22/20 Freeport McMoRan reports Q3 EPS 22c, consensus 21c 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open 07/23/20 Freeport McMoRan reports Q2 EPS 3c, consensus (2c) FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 09/16/20 CFO says Freeport not wanting to be 'distracted' by buyout bids, Reuters reports 08/24/20 Workers bar access to Freeport Indonesia's Grasberg mine, Reuters reports FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 11/11/20 Fly Intel: After-Hours Movers 01/26/21 Freeport McMoRan - FCX FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 01/07/21 Early notable gainers among liquid option names on January 7th 01/04/21 Early notable gainers among liquid option names on January 4th 12/31/20 Unusually active option classes on open December 31st 12/30/20 Freeport McMoRan call volume above normal and directionally bullish
Initiation	Sapiens initiated with a Buy at Jefferies » 07:58 01/20/21 01/20 07:58 01/20/21 07:58 SPNS Sapiens $31.51 / +0.49 (+1.58%) Jefferies analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly SPNS Sapiens $31.51 / +0.49 (+1.58%) 12/16/20 Sapiens partners with TruthMD for advanced data analytics 11/09/20 Sapiens acquires Tia Technology, terms not disclosed 09/24/20 Sapiens partners with GreenRoad Technologies for auto insurance solution 09/08/20 Sapiens appoints Jeannine Sargent to its board of director SPNS Sapiens $31.51 / +0.49 (+1.58%) 01/13/21 Fly Intel: Top five analyst initiations 01/13/21 Goldman Sachs Sapiens initiated with a Neutral at Goldman Sachs 12/22/20 Fly Intel: Top five analyst initiations 12/22/20 Citi Sapiens initiated with a Buy at Citi SPNS Sapiens $31.51 / +0.49 (+1.58%) 08/04/20 Sapiens raises FY20 revenue view to $376M-$381M from $368M-$377M 08/04/20 Sapiens reports Q2 EPS 26c, consensus 21c 16 Oct SPNS Sapiens $31.51 / +0.49 (+1.58%) 10/13/20 Fly Intel: After-Hours Movers
Recommendations	Comerica price target raised to $72 from $65 at B. Riley Securities » 07:57 01/20/21 01/20 07:57 01/20/21 07:57 CMA Comerica $63.85 / +0.16 (+0.25%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options CMA Comerica $63.85 / +0.16 (+0.25%) 08/19/20 Comerica partners with Minority Depository Institutions 07/21/20 Comerica up 4.8% after reporting Q2 results CMA Comerica $63.85 / +0.16 (+0.25%) 01/14/21 Raymond James Comerica upgraded to Outperform from Market Perform at Raymond James 01/14/21 Raymond James Comerica upgraded to Outperform from Market Perform at Raymond James 01/13/21 Baird Comerica downgraded to Neutral following rally at Baird 01/13/21 Baird Comerica downgraded to Neutral from Outperform at Baird CMA Comerica $63.85 / +0.16 (+0.25%) 01/19/21 Comerica reports Q4 EPS $1.49, consensus $1.19 10/20/20 Comerica reports Q3 EPS $1.44, consensus 83c 07/21/20 Comerica reports Q2 EPS 80c, consensus 21c 02/02/21 Texas Bank Virtual Investor Trip 03/11/21 Virtual Atlanta and Texas Bank Summit 04/20/21 Comerica - CMA CMA Comerica $63.85 / +0.16 (+0.25%) 10/20/20 Early notable gainers among liquid option names on October 20th
Recommendations	Zions Bancorp price target raised to $57 from $55 at B. Riley Securities » 07:56 01/20/21 01/20 07:56 01/20/21 07:56 ZION Zions Bancorp $49.35 / +0.19 (+0.39%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events Options ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/07/21 B. Riley Securities Zions Bancorp price target raised to $55 from $52 at B. Riley Securities 01/04/21 Barclays Zions Bancorp downgraded to Equal Weight with $50 target at Barclays 01/04/21 Barclays Zions Bancorp downgraded to Equal Weight from Overweight at Barclays 12/07/20 Evercore ISI Zions Bancorp upgraded to Outperform from In Line at Evercore ISI ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/19/21 Zions Bancorp reports Q4 EPS $1.66, consensus $1.02 01/19/21 Notable companies reporting after market close 10/19/20 Zions Bancorp reports Q3 EPS $1.01, consensus 88c 07/20/20 Zions Bancorp reports Q2 EPS 34c, consensus 38c ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/19/21 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: After-Hours Movers 04/19/21 Zions Bancorp - ZION ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/19/21 Zions Bancorp options imply 4.3% move in share price post-earnings

Upgrade	Pola Orbis upgraded to Buy from Hold at Jefferies » 07:56 01/20/21 01/20 07:56 01/20/21 07:56 PORBF Pola Orbis / + Jefferies analyst Mitsuko… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PORBF Pola Orbis / + 01/07/21 Goldman Sachs Pola Orbis upgraded to Buy from Neutral at Goldman Sachs
Downgrade	Ceragon Networks double-downgraded to Underperform from Buy at Needham » 07:56 01/20/21 01/20 07:56 01/20/21 07:56 CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) Needham analyst Alex… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) 09/16/20 Ceragon Networks' new quad-carrier outdoor solution selected by 5G providers 08/03/20 Ceragon Networks selected by Orange Niger for 4G deployment support CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) 07:17 Today Needham Ceragon Networks downgraded to Underperform from Buy at Needham 05/04/20 Needham Ceragon longer-term news continues to improve, says Needham 04/17/20 Needham Ceragon Networks upgraded to Buy from Hold at Needham 04/17/20 Needham Ceragon Networks upgraded to Buy from Hold at Needham CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) 11/02/20 Ceragon Networks reports Q3 EPS 3c, consensus (1c) 08/03/20 Ceragon Networks reports Q2 EPS (6c), consensus (7c) 02/08/21 Ceragon Networks - CRNT
Recommendations	SunCoke Energy price target raised to $8 from $7 at B. Riley Securities » 07:55 01/20/21 01/20 07:55 01/20/21 07:55 SXC SunCoke Energy $5.78 / +0.155 (+2.76%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SXC SunCoke Energy $5.78 / +0.155 (+2.76%) 12/18/20 SunCoke Energy falls -9.4% 11/06/20 SunCoke Energy cuts FY20 domestic coke production view to 3.75M tons from 4.3M 10/14/20 SunCoke Energy rises 8.2% SXC SunCoke Energy $5.78 / +0.155 (+2.76%) 09/18/20 B. Riley FBR SunCoke story misunderstood, share rally to continue, says B. Riley FBR 08/04/20 B. Riley FBR SunCoke Energy price target raised to $8 from $7 at B. Riley FBR 02/06/20 Benchmark Benchmark starts SunCoke Energy at Hold, sees too much ArcelorMittal uncertainty 02/06/20 Benchmark SunCoke Energy initiated with a Hold at Benchmark SXC SunCoke Energy $5.78 / +0.155 (+2.76%) 11/06/20 SunCoke Energy reports Q3 adj. EPS (3c), two estimates (4c)
Recommendations	Peer's results show positive read-through for Camping World, says Monness Crespi » 07:55 01/20/21 01/20 07:55 01/20/21 07:55 CWH Camping World $31.77 / +0.66 (+2.12%) Monness Crespi analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CWH Camping World $31.77 / +0.66 (+2.12%) 12/16/20 Camping World, Lordstown Motors partner on EV service network 11/24/20 Camping World acquires Paul Sherry RV in Piqua Ohio 11/19/20 Camping World to acquire All RV Needs in Oregon 11/18/20 Camping World declares quarterly and special dividend totaling $1.00 per share CWH Camping World $31.77 / +0.66 (+2.12%) 12/16/20 JPMorgan JPMorgan reiterates $45 target on Camping World after Lordstown pact 11/04/20 BMO Capital Camping World price target lowered to $30 from $36 at BMO Capital 09/28/20 JPMorgan RV shipments rose for third straight month in August, says JPMorgan 09/16/20 JPMorgan Camping World price target raised to $44 from $40 at JPMorgan CWH Camping World $31.77 / +0.66 (+2.12%) 11/02/20 Camping World CEO confirms previously issued FY21 adjusted EBITDA target 11/02/20 Camping World raises FY20 adjusted EBITDA view to $495M-$515M from $460M-$490M 11/02/20 Camping World reports Q3 EPS $1.44, consensus 96c 08/05/20 Camping World sees 2020 as company's 'most profitable' year ever 20 Aug CWH Camping World $31.77 / +0.66 (+2.12%) 12/15/20 Lordstown, Camping World to make 'special announcement,' WKBN says CWH Camping World $31.77 / +0.66 (+2.12%) 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 11/16/20 Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades 11/02/20 Fly Intel: Wall Street's top stories for Monday 11/02/20 Fly Intel: Wall Street's top stories at midday 02/25/21 Camping World - CWH CWH Camping World $31.77 / +0.66 (+2.12%) 12/16/20 Call trader flips Camping World calls for 1day loss 12/16/20 Unusually active option classes on open December 16th 12/15/20 Camping World call volume above normal and directionally bullish 11/23/20 Camping World call volume above normal and directionally bullish
Conference/Events	Mesoblast participates in a conference call with Cantor Fitzgerald » 07:55 01/20/21 01/20 07:55 01/20/21 07:55 MESO Mesoblast $9.39 / -0.3 (-3.10%) Biopharma Analyst Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options MESO Mesoblast $9.39 / -0.3 (-3.10%) 01/19/21 Alpha short Mesoblast, expects chronic lower back pain Phase 3 trial to fail 01/11/21 Mesoblast announces additional results from DREAM-HF trial 12/17/20 Mesoblast's COVID remestemcel trial not likely to meet mortality reduction goal 12/15/20 Mesoblast trading halted, news pending MESO Mesoblast $9.39 / -0.3 (-3.10%) 01/19/21 Jefferies Mesoblast downgraded to Hold from Buy at Jefferies 12/22/20 Fly Intel: Top five analyst downgrades 12/22/20 Maxim Mesoblast downgraded to Hold from Buy at Maxim 12/18/20 H.C. Wainwright Mesoblast price target lowered to $16 from $20 at H.C. Wainwright MESO Mesoblast $9.39 / -0.3 (-3.10%) 11/19/20 Mesoblast reports Q3 EPS ($4.21), two estimates (26c) 08/26/20 Notable companies reporting after market close MESO Mesoblast $9.39 / -0.3 (-3.10%) 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 01/11/21 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: Wall Street's top stories for Tuesday 08:00 Today Mesoblast - MESO MESO Mesoblast $9.39 / -0.3 (-3.10%) 01/11/21 Unusually active option classes on open January 11th 12/22/20 Largest borrow rate increases among liquid names 12/15/20 Largest borrow rate increases among liquid names 12/11/20 Largest borrow rate increases among liquid names

Recommendations	Rekor Systems price target raised to $14 from $7.50 at B. Riley Securities » 07:54 01/20/21 01/20 07:54 01/20/21 07:54 REKR Rekor Systems $11.08 / +0.5 (+4.73%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options REKR Rekor Systems $11.08 / +0.5 (+4.73%) 01/14/21 Rekor Systems releases update to Rekor Scout software 01/07/21 State of Oklahoma uses Rekor One to power UVED program 11/09/20 Oklahoma selects Rekor Systems to mitigate uninsured motorists 10/22/20 Pennsylvania District Attorney's Office signs Rekor for vehicle recognition REKR Rekor Systems $11.08 / +0.5 (+4.73%) 09/08/20 B. Riley FBR Rekor Systems price target raised to $8 from $6 at B. Riley FBR 07/21/20 B. Riley FBR Rekor Systems transferred with Buy rating at B. Riley FBR 04/14/20 B. Riley FBR Rekor Systems initiated with Buy on 'significant' opportunity at B. Riley FBR 04/14/20 B. Riley FBR Rekor Systems initiated with a Buy at B. Riley FBR REKR Rekor Systems $11.08 / +0.5 (+4.73%) 08/03/20 Rekor Systems reports Q2 EPS (3c), consensus (12c) REKR Rekor Systems $11.08 / +0.5 (+4.73%) 11/02/20 Rekor Systems shares have 58% downside potential, Seeking Alpha contributor says REKR Rekor Systems $11.08 / +0.5 (+4.73%) 09/23/20 Four new option listings and one option delisting on September 23rd
Hot Stocks	Pfizer, BioNTech: COVID-19 vaccine elicits antibodies neutralizing pseudovirus » 07:54 01/20/21 01/20 07:54 01/20/21 07:54 PFE Pfizer $36.74 / +0.03 (+0.08%) , BNTX BioNTech $104.98 / +3.435 (+3.38%) Pfizer Inc. (PFE) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 01/14/21 Pfizer says FDA approves supplemental NDA for Xalkori 01/14/21 Oragenics issues letter to stockholders on Terra CoV-2 01/13/21 Siga Technologies: Meridian Medical to purchase up to $33M of oral TPOXX 01/12/21 Canada orders 20M more doses of Pfizer, BioNTech Covid vaccine BNTX BioNTech $104.98 / +3.435 (+3.38%) 01/12/21 Canada orders 20M more doses of Pfizer, BioNTech Covid vaccine 01/08/21 Pfizer, BioNTech COVID vaccine elicits antibodies that neutralize mutation 01/07/21 BioNTech reports publication of preclinical data on novel mRNA vaccine approach 01/04/21 FDA continues to recommend authorized COVID vaccine dosing schedule PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg BNTX BioNTech $104.98 / +3.435 (+3.38%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 12/29/20 Citi Arcturus selloff brings 'very good' buying opportunity, says Citi 12/22/20 Roth Capital Translate Bio price target raised to $37 from $30 at Roth Capital 12/15/20 Jefferies Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play' PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 BNTX BioNTech $104.98 / +3.435 (+3.38%) 08/11/20 BioNTech reports Q2 EPS (EUR38c), consensus (EUR24c) 07/31/20 Pfizer, BioNTech to supply Japan with 120M doses of BNT162 vaccine candidate 23 Jul 06 Feb PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 06:09 Today Pfizer/BioNTech vaccine likely to be effective against Covid variant, FT reports 01/18/21 NY Gov. asks Pfizer to directly sell COVID vaccine doses, Reuters reports 01/12/21 Pfizer, health officials investigating post-vaccine fatality, Bloomberg says 01/11/21 Pfizer says HHS would need to approve direct sales of COVID vaccine, CNBC says BNTX BioNTech $104.98 / +3.435 (+3.38%) 06:09 Today Pfizer/BioNTech vaccine likely to be effective against Covid variant, FT reports 01/04/21 Pfizer, BioNTech offered South Africa discounted vaccines, Bloomberg says 12/30/20 Nurse tests positive for COVID-19 week after getting Pfizer vaccine, KGTV says 12/22/20 White House, Pfizer near deal for tens of millions of vaccine doses, WP says PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday BNTX BioNTech $104.98 / +3.435 (+3.38%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/02/21 2021 London Global Healthcare Virtual Conference 02/02/21 Pfizer - PFE 01/24/21 PDUFA Date for Xalkori (Crizotinib) - January 2021 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th 12/11/20 Notable open interest changes for December 11th BNTX BioNTech $104.98 / +3.435 (+3.38%) 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names 11/20/20 Unusually active option classes on open November 20th 11/02/20 Largest borrow rate increases among liquid names
Downgrade	Fanuc downgraded to Hold from Buy at Jefferies » 07:52 01/20/21 01/20 07:52 01/20/21 07:52 FANUY Fanuc $0.00 / + (+0.00%) Jefferies analyst Sho… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FANUY Fanuc $0.00 / + (+0.00%) 12/22/20 JPMorgan Fanuc upgraded to Neutral from Underweight at JPMorgan 11/20/20 Goldman Sachs Fanuc upgraded to Neutral from Sell at Goldman Sachs 09/04/20 Mizuho Fanuc upgraded to Buy from Neutral at Mizuho 08/05/20 Daiwa Fanuc downgraded to Underperform from Neutral at Daiwa
Recommendations	Net 1 UEPS price target raised to $7 from $5 at B. Riley Securities » 07:52 01/20/21 01/20 07:52 01/20/21 07:52 UEPS Net 1 UEPS $5.03 / +0.27 (+5.67%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events UEPS Net 1 UEPS $5.03 / +0.27 (+5.67%) 08/05/20 Net 1 UEPS CEO Herman Kotze to step down at end of September UEPS Net 1 UEPS $5.03 / +0.27 (+5.67%) 09/15/20 B. Riley FBR Net 1 UEPS 'stands out as significantly undervalued,' says B. Riley FBR 09/08/20 B. Riley FBR Net 1 UEPS transferred with Buy rating, $5 target at B. Riley FBR UEPS Net 1 UEPS $5.03 / +0.27 (+5.67%) 12/21/20 Fly Insider: Net 1 UEPS, GrafTech among weeks notable insider trades 11/30/20 Fly Insider: Merrimack, Catalent among weeks notable insider trades 10/05/20 Fly Insider: Odonate Therapeutics, Carvana among week's notable insider trades 02/05/21 Net 1 UEPS - UEPS
Recommendations	Netflix price target raised to $650 from $600 at Monness Crespi » 07:52 01/20/21 01/20 07:52 01/20/21 07:52 NFLX Netflix $501.85 / +3.9 (+0.78%) Monness Crespi analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $501.85 / +3.9 (+0.78%) 07:31 Today Canaccord Netflix price target raised to $670 from $630 at Canaccord 07:26 Today Deutsche Bank Netflix price target raised to $600 from $580 at Deutsche Bank 07:23 Today Cowen Netflix price target raised to $675 from $650 at Cowen 07:16 Today KeyBanc Netflix price target raised to $650 from $634 at KeyBanc NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $501.85 / +3.9 (+0.78%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st

Recommendations	Eagle Bulk Shipping price target lowered to $27.25 from $31.50 at B. Riley » 07:50 01/20/21 01/20 07:50 01/20/21 07:50 EGLE Eagle Bulk Shipping / + B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events EGLE Eagle Bulk Shipping / + 12/29/20 Eagle Bulk Shipping acquires two SDARI-64 scrubber-fitted Ultramax bulkcarriers 12/22/20 Eagle Bulk Shipping becomes signatory to Sea Cargo Charter 12/16/20 Eagle Bulk Shipping acquires Ultramax bulkcarrier for $16M 09/15/20 Eagle Bulk Shipping announces effectiveness of 1-for-7 reverse stock split EGLE Eagle Bulk Shipping / + 12/24/20 Noble Capital Eagle Bulk Shipping price target lowered to $30 from $32.50 at Noble Capital 07/29/20 DNB Markets Eagle Bulk Shipping upgraded to Buy from Hold at DNB Markets 03/09/20 DNB Markets Eagle Bulk Shipping downgraded to Hold from Buy at DNB Markets 01/27/20 Fearnley Eagle Bulk Shipping downgraded to Hold from Buy at Fearnley EGLE Eagle Bulk Shipping / + 11/05/20 Eagle Bulk Shipping reports Q3 EPS ($1.09), consensus (69c) 18 Dec 01/19/21 17th Annual Small & Microcap Virtual Investor Conference
Recommendations	Viridian Therapeutics price target raised to $28 on assumption at Jefferies » 07:50 01/20/21 01/20 07:50 01/20/21 07:50 VRDN Viridian Therapeutics $23.10 / -0.19 (-0.82%) Jefferies analyst Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News VRDN Viridian Therapeutics $23.10 / -0.19 (-0.82%) 01/19/21 Miragen Therapeutics appoints Jonathan Violin as CEO, Barrett Katz as CMO 01/19/21 Miragen Therapeutics changes name to Viridian Therapeutics
Hot Stocks	Lithium Americas trading halted, news pending 07:50 01/20/21 01/20 07:50 01/20/21 07:50 LAC Lithium Americas $26.80 / +6.27 (+30.54%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/19/21 Lithium Americas rises 30.6% 01/19/21 Lithium Americas rises 19.6% 01/19/21 Lithium Americas rises 15.7% 01/11/21 Lithium Americas falls -9.6% LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/06/21 Canaccord Lithium Americas price target raised to C$20 from C$11.50 at Canaccord 12/23/20 Stifel Stifel starts Lithium Americas with Buy, sees 'attractive upside' 12/22/20 Stifel Lithium Americas initiated with a Buy at Stifel 10/21/20 Roth Capital Lithium Americas downgraded to Neutral from Buy at Roth Capital LAC Lithium Americas $26.80 / +6.27 (+30.54%) 08/14/20 Lithium Americas reports Q2 EPS (7c) vs. (7c) last year 20 Jan LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/19/21 Fly Intel: After-Hours Movers 12/22/20 Fly Intel: After-Hours Movers 09/23/20 Tesla, lithium names under pressure as Wall Street digests Battery Day LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/13/21 Lithium Americas call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd 12/22/20 Lithium Americas call volume above normal and directionally bullish 12/18/20 Largest borrow rate increases among liquid names
Recommendations	Charles Schwab price target raised to $70 from $60 at Wells Fargo » 07:47 01/20/21 01/20 07:47 01/20/21 07:47 SCHW Charles Schwab $59.26 / +0.49 (+0.83%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SCHW Charles Schwab $59.26 / +0.49 (+0.83%) 12/21/20 Charles Schwab unit fined GBP8.96M by U.K.'s Financial Conduct Authority 11/13/20 Charles Schwab reports October core new assets of $25.6B 10/29/20 Charles Schwab CFO says near-term accretion math 'better' for TD Ameritrade deal 10/26/20 Charles Schwab to cut roughly 3% of combined Schwab-TD Ameritrade workforce SCHW Charles Schwab $59.26 / +0.49 (+0.83%) 07:43 Today Deutsche Bank Charles Schwab price target raised to $73 from $70 at Deutsche Bank 01/12/21 BofA Charles Schwab upgraded to Buy from Neutral at BofA 01/05/21 Wolfe Research Charles Schwab downgraded to Underperform from Peer Perform at Wolfe Research 12/01/20 Fly Intel: Top five analyst upgrades SCHW Charles Schwab $59.26 / +0.49 (+0.83%) 01/19/21 Charles Schwab reports Q4 adjusted EPS 74c, consensus 71c 10/15/20 Charles Schwab reports Q3 adj. EPS 51c, consensus 46c 10/14/20 Notable companies reporting before tomorrow's open 10/14/20 Notable companies reporting before tomorrow's open SCHW Charles Schwab $59.26 / +0.49 (+0.83%) 11/17/20 Trading platform Robinhood may go public next year, Bloomberg reports 10/15/20 Robinhood says almost 2,000 brokerage accounts hacked, Bloomberg reports SCHW Charles Schwab $59.26 / +0.49 (+0.83%) 10/15/20 Fly Intel: Pre-market Movers 07/27/20 Fly Insider: CASI Pharma, Datadog among weeks notable insider trades SCHW Charles Schwab $59.26 / +0.49 (+0.83%) 12/18/20 Charles Schwab call volume above normal and directionally bullish 11/10/20 Charles Schwab put volume heavy and directionally bearish 10/15/20 Early notable gainers among liquid option names on October 15th 10/06/20 Charles Schwab put volume heavy and directionally bearish
Upgrade	Cognizant upgraded to Outperform from Market Perform at William Blair » 07:47 01/20/21 01/20 07:47 01/20/21 07:47 CTSH Cognizant $79.72 / -0.53 (-0.66%) William Blair analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CTSH Cognizant $79.72 / -0.53 (-0.66%) 01/19/21 Cognizant to acquire Magenic Technologies, terms not disclosed 01/11/21 Cognizant to acquire Linium, terms not disclosed 01/10/21 Cognizant to acquire Servian 12/21/20 Cognizant acquires Inawisdom, terms undisclosed CTSH Cognizant $79.72 / -0.53 (-0.66%) 01/06/21 Wolfe Research Cognizant upgraded to Peer Perform from Underperform at Wolfe Research 12/29/20 Credit Suisse Cognizant price target raised to $91 from $79 at Credit Suisse 12/18/20 Wells Fargo Cognizant resumed with an Overweight at Wells Fargo 12/11/20 JPMorgan Cognizant upgraded to Overweight with $93 target at JPMorgan CTSH Cognizant $79.72 / -0.53 (-0.66%) 10/28/20 Cognizant raises FY20 adjusted EPS view to $3.63-$3.67 from $3.48-$3.58 10/28/20 Cognizant reports Q3 adjusted EPS 97c, consensus 90c 10/28/20 Cognizant reports Q3 adjusted EPS 97c, consensus 90c 10/28/20 Notable companies reporting after market close CTSH Cognizant $79.72 / -0.53 (-0.66%) 07/23/20 Over 1,000 Twitter workers had ability to aid in security hacks, Reuters says CTSH Cognizant $79.72 / -0.53 (-0.66%) 10/28/20 Fly Intel: After-Hours Movers 07/29/20 Fly Intel: After-Hours Movers 02/11/21 Technology & Internet Virtual Conference 02/03/21 Cognizant - CTSH CTSH Cognizant $79.72 / -0.53 (-0.66%) 12/11/20 Early notable gainers among liquid option names on December 11th 10/29/20 Early notable gainers among liquid option names on October 29th 09/11/20 Early notable gainers among liquid option names on September 11th

Events

Earnings calls, analyst events, roadshows and more

FNB
Today at 08:15

F.N.B. - FNB Conference Calls
MS
Today at 08:30

Morgan Stanley - MS Conference Calls
PG
Today at 08:30

Procter & Gamble - PG Conference Calls
UNH
Today at 08:45

UnitedHealth - UNH Conference Calls
Today at 08:55

Redbook Store Sales Y/Y: 1/16/21 Government Event
USB
Today at 09:00

U.S. Bancorp - USB Conference Calls
PNFP
Today at 09:30

Pinnacle Financial - PNFP Conference Calls
NJR
Today at 09:30

New Jersey Resources Corp Firm Sponsored Meetings
Today at 10:00

Housing Market Index: January 2021 Government Event
FAST
Today at 10:00

Fastenal - FAST Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright $17.00-18.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald $1.90-2.00 CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $64.18 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel $22.00-23.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE $13.96 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares
Fri	No deals

View All Syndicate Announcements »

Husqvarna downgraded to Hold from Buy at Pareto

TODAY'S FREE FLY STORIES

Get Full Fly Access